Current status and future goals of the pharmacologic reduction of portal hypertension
- 31 July 1990
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 160 (1) , 19-25
- https://doi.org/10.1016/s0002-9610(05)80863-3
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosisLiver International, 1987
- Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosisJournal of Hepatology, 1987
- Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosisJournal of Hepatology, 1987
- Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosisDigestive Diseases and Sciences, 1986
- Short–Term Effects of Propranolol on Portal Venous PressureHepatology, 1986
- Measurement of azygos blood flow by a continuous thermodilution method in liver disease.Kanzo, 1986
- Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosisJournal of Hepatology, 1985
- Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in CirrhosisHepatology, 1984
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983
- The Effect of Propranolol on Portal Hypertension in Patients With Cirrhosis: A Hemodynamic StudyHepatology, 1982